Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFR(L858R/T790M) kinase inhibitors
2022-01
发表期刊BIOORGANIC CHEMISTRY (IF:4.5[JCR-2023],4.7[5-Year])
ISSN0045-2068
EISSN1090-2120
卷号118
发表状态已发表
DOI10.1016/j.bioorg.2021.105471
摘要On the basis of N-(3-amino-4-methoxyphenyl)acrylamide scaffold, a series of novel compounds containing 3-substitutional-1-methyl-1H-indole, 2-substitutional pyrrole or thiophene moieties were synthesized and their in vitro antiproliferation activities against A549 and H1975 cell lines were evaluated. The results indicated that most of the compounds showed moderate to excellent antitumor activities. Especially, compounds 9a (A549 IC50 = 1.96 mu M, H1975 IC50 = 0.095 mu M), 17i (A549 IC50 = 4.17 mu M, H1975 IC50 = 0.052 mu M), 17j (A549 IC50 = 1.67 mu M, H1975 IC50 = 0.061 mu M) exhibited comparable antitumor activities and selectivity ratios compared to the positive control osimertinib (A549 IC50 = 2.91 mu M, H1975 IC50 = 0.064 mu M). In vitro inhibitory activities against EGFR kinases containing different mutations were also tested. Compound 17i showed remarkable inhibitory activity (with IC50 value of 1.7 nM) to EGFR(L858R/T790M) kinase and selectivity (22-folds compared to EGFRWT kinase). Furthermore, acridine orange/ethidium bromide (AO/EB) staining assay, cell apoptosis assay, cell cycle distribution assay and wound-healing assay of the compounds 9a and 17i were performed on H1975 cell line. The results showed dose-dependent activities of the induction of apoptosis, G0/G1-phase arrestation and inhibition of migration, which were similar to the positive control osimertinib. Additionally, molecular docking analysis was performed to seek the possible binding mode between the selected compounds (9a, 17i-17j) and EGFR(L858R/T790M) kinase. The results demonstrated that compound 17i is a promising candidate and worth further study.
关键词N-(3-amino-4-methoxyphenyl)acrylamide derivatives EGFR-TKIs Kinase selectivity Antitumor activity Docking study
URL查看原文
收录类别SCI ; SCIE ; IC
语种英语
资助项目National Natural Science Foundation of China[21807055] ; Pre-declaration Foundation of Liaoning University[LDGY2019002] ; National College Students Innovation and Entrepreneurship Training Program[D202011262238223108] ; Natural Science Foundation of Liaoning Provincial Department of Science and Technology[2019-ZD-0191] ; General Project of Education Department of Liaoning Province[LJC201907]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
WOS类目Biochemistry & Molecular Biology ; Chemistry, Organic
WOS记录号WOS:000823056200005
出版者ACADEMIC PRESS INC ELSEVIER SCIENCE
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/214743
专题iHuman研究所_公共科研平台_IT平台
通讯作者Liu, Ju; Chen, Ye
作者单位
1.Liaoning Univ, Coll Pharm, 66 Chongshan Rd, Shenyang 110036, Peoples R China
2.API Engn Technol Res Ctr Liaoning Prov, 66 Chongshan Rd, Shenyang 110036, Peoples R China
3.Small Mol Targeted Drug R&D Engn Res Ctr Liaoning, 66 Chongshan Rd, Shenyang 110036, Peoples R China
4.ShanghaiTech Univ, iHuman Inst, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China
推荐引用方式
GB/T 7714
Ding, Shi,Dong, Xiaoyong,Gao, Ziye,et al. Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFR(L858R/T790M) kinase inhibitors[J]. BIOORGANIC CHEMISTRY,2022,118.
APA Ding, Shi.,Dong, Xiaoyong.,Gao, Ziye.,Zheng, Xiangshan.,Ji, Jingchao.,...&Chen, Ye.(2022).Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFR(L858R/T790M) kinase inhibitors.BIOORGANIC CHEMISTRY,118.
MLA Ding, Shi,et al."Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFR(L858R/T790M) kinase inhibitors".BIOORGANIC CHEMISTRY 118(2022).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Ding, Shi]的文章
[Dong, Xiaoyong]的文章
[Gao, Ziye]的文章
百度学术
百度学术中相似的文章
[Ding, Shi]的文章
[Dong, Xiaoyong]的文章
[Gao, Ziye]的文章
必应学术
必应学术中相似的文章
[Ding, Shi]的文章
[Dong, Xiaoyong]的文章
[Gao, Ziye]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。